Pfizer Inc. (PFE.DE) XETRA

21.85

-0.13(-0.59%)

Updated at June 02 05:35PM

Currency In EUR

Pfizer Inc.

Address

235 East 42nd Street

New York City, NY 10017

United States of America (the)

Phone

212 733 2323

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

81000

First IPO Date

December 28, 2007

Key Executives

NameTitlePayYear Born
Albert BourlaChairman of the Board & Chief Executive Officer7.84M1962
Douglas LanklerExecutive Vice President & Chief Legal Officer3.96M1966
David DentonExecutive Vice President & Chief Financial Officer4.12M1965
Aamir MalikExecutive Vice President & Chief U.S. Commercial Officer4.2M1976
Chris Boshoff FMedSciChief Scientific Officer and President of Research & Development4.46M1964
Michael S. VincentSenior Vice President and Chief Scientific Officer of Inflammation & Immunology0N/A
Dennis HancockExecutive VP & Chief Information Officer0N/A
Francesca DeMartinoChief Investor Relations Officer0N/A
Jennifer DamicoSenior Vice President, Controller & Principal Accounting Officer01969
Lidia L. FonsecaExecutive Vice President and Chief Digital & Technology Officer01969
Payal Sahni BecherChief People Experience Officer & Executive Vice President01975

Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.